Literature DB >> 21426336

Nicotinamide phosphoribosyltransferase and lipid accumulation in macrophages.

Tuva Dahl1, Trine Ranheim, Sverre Holm, Rolf Berge, Pål Aukrust, Bente Halvorsen.   

Abstract

BACKGROUND: Accumulation of modified low-density lipoprotein (LDL) in macrophages is a key event in all stages of atherogenesis. We have previously shown increased level of nicotinamide phosphoribosyltransferase (nampt) in symptomatic, compared to asymptomatic, atherosclerotic carotid lesions, primarily located to macrophages. Here we sought to investigate the regulation and effect of intracellular nampt in macrophages.
MATERIALS AND METHODS: The expression of nampt was assessed by real-time PCR in THP-1 cells that was exposed to different pro-atherogenic stimuli. The effect of nampt on lipid accumulation was examined in phorbol myristate acetate-differentiated THP-1 and in primary monocyte-derived macrophages.
RESULTS: Our main findings were: (1) Nampt is increased during macrophage differentiation. (2) Tumor necrosis factor (TNF)α, oxidized (ox)LDL, and hypoxia increased nampt expression in macrophages, with further enhancing effect when these stimuli were combined. The effect of hypoxia seems to involve hypoxia inducing factor 1α. (3) Silencing of nampt increased lipid accumulation in macrophages as shown by increased protein levels of the lipid droplet marker adipose differentiation-related protein (ADRP). (4) A specific inhibitor of nampt enzymatic activity, increased ADRP and cholesterol levels in oxLDL stimulated macrophages, and enhanced the binding of acetylated LDL in these cells. (5). Nampt inhibition decreased the relative amount of cholesterol efflux in oxLDL-exposed macrophages.
CONCLUSIONS: Our data suggest that the regulation of nampt in macrophages is linked to pro-atherogenic stimuli, potentially mediating counteracting effects on lipid accumulation and foam cell formation. These findings suggest a rather complex role of nampt in atherogenesis, potentially mediating both adaptive and maladaptive responses.
© 2011 The Authors. European Journal of Clinical Investigation © 2011 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21426336     DOI: 10.1111/j.1365-2362.2011.02515.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  8 in total

1.  Niacin: an old lipid drug in a new NAD+ dress.

Authors:  Mario Romani; Dina Carina Hofer; Elena Katsyuba; Johan Auwerx
Journal:  J Lipid Res       Date:  2019-02-19       Impact factor: 5.922

2.  Visfatin induces cholesterol accumulation in macrophages through up-regulation of scavenger receptor-A and CD36.

Authors:  Fenghua Zhou; Yunyun Pan; Zhiyong Huang; Yuhua Jia; Xiaoshan Zhao; Yuyao Chen; Jianxin Diao; Qiang Wan; Xiaobing Cui
Journal:  Cell Stress Chaperones       Date:  2013-03-15       Impact factor: 3.667

3.  Nicotinamide phosphoribosyltransferase aggravates inflammation and promotes atherosclerosis in ApoE knockout mice.

Authors:  Yuan-Yuan Kong; Guo-Qiang Li; Wen-Jie Zhang; Xia Hua; Can-Can Zhou; Tian-Ying Xu; Zhi-Yong Li; Pei Wang; Chao-Yu Miao
Journal:  Acta Pharmacol Sin       Date:  2019-03-04       Impact factor: 6.150

Review 4.  NAD+ homeostasis in health and disease.

Authors:  Mario Romani; Dina Hofer; Elena Katsyuba; Johan Auwerx
Journal:  Nat Metab       Date:  2020-01-20

5.  Adipo/cytokines in atherosclerotic secretomes: increased visfatin levels in unstable carotid plaque.

Authors:  Teresa Auguet; Gemma Aragonès; Esther Guiu-Jurado; Alba Berlanga; Marta Curriu; Salomé Martinez; Ajla Alibalic; Carmen Aguilar; María-Luisa Camara; Esteban Hernández; Xavier Ruyra; Vicente Martín-Paredero; Cristóbal Richart
Journal:  BMC Cardiovasc Disord       Date:  2016-07-08       Impact factor: 2.298

6.  Nicotinamide phosphoribosyltransferase may be involved in age-related brain diseases.

Authors:  Li-Ying Liu; Feng Wang; Xia-Yan Zhang; Peng Huang; Yun-Bi Lu; Er-Qing Wei; Wei-Ping Zhang
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

7.  NAMPT knockdown attenuates atherosclerosis and promotes reverse cholesterol transport in ApoE KO mice with high-fat-induced insulin resistance.

Authors:  Shengbing Li; Cong Wang; Ke Li; Ling Li; Mingyuan Tian; Jing Xie; Mengliu Yang; Yanjun Jia; Junying He; Lin Gao; Guenther Boden; Hua Liu; Gangyi Yang
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

Review 8.  The Roles and Associated Mechanisms of Adipokines in Development of Metabolic Syndrome.

Authors:  Ji-Eun Kim; Jin-Sun Kim; Min-Jee Jo; Eunjung Cho; Shin-Young Ahn; Young-Joo Kwon; Gang-Jee Ko
Journal:  Molecules       Date:  2022-01-06       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.